(PDF) In Vivo Retargeting of Adenovirus Type 5 to v 6

In Vivo Retargeting of Adenovirus Type 5 to v 6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake Following Systemic Delivery

Journal of Virology - United States

doi 10.1128/jvi.00445-09

Full Text

Abstract

Available in full text

Categories

Date

April 15, 2009

Authors

Publisher

American Society for Microbiology

Related search

845. An Ad5 Vector Retargeted to Αvβ6 Displays Improved Tumour Transduction Combined With Reduced Liver Uptake Following Systemic Delivery

Molecular Therapy

Molecular Medicine

Molecular Biology

English

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

Journal of Virology

English

Integrin Alpha v Beta 5 Selectively Promotes Adenovirus Mediated Cell Membrane Permeabilization

Journal of Cell Biology

English

Critical Role for v 6 Integrin in Enamel Biomineralization

Journal of Cell Science

English

In Vivo Potential Effects of Adenovirus Type 5 E1A and E1B on Lung Carcinogenesis and Lymphoproliferative Inflammation

Journal of Virology

English

Seroprevalence of Neutralizing Antibodies Against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients

Frontiers in Immunology

English

Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer in Vivo

Journal of Cancer

English

Gene Delivery to Skeletal Muscle Results in Sustained Expression and Systemic Delivery of a Therapeutic Protein

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Retargeting to EGFR Enhances Adenovirus Infection Efficiency of Squamous Cell Carcinoma

Archives of Otolaryngology–Head & Neck Surgery

English